Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Magnetic particles that can be precisely controlled under a magnetic field and transduce energy from the applied field open the way for innovative cancer treatment. Although these particles represent an area of active development for drug delivery and magnetic hyperthermia, the in vivo anti-tumor effect under a low-frequency magnetic field using magnetic particles has not yet been demonstrated. To-date, induced cancer cell death via the oscillation of nanoparticles under a low frequency magnetic field has only been observed in-vitro. In this report, we demonstrate the successful use of spin-vortex, disk-shaped permalloy magnetic particles in a low-frequency, rotating magnetic field for the in vitro and in vivo destruction of glioma cells. The internalized nanomagnets align themselves to the plane of the rotating magnetic field, creating a strong mechanical force which damages the cancer cell structure inducing programmed cell death. In vivo, the magnetic field treatment successfully reduces the brain tumor size and increases the survival rate of mice bearing intracranial glioma xenografts, without adverse side effects. This study demonstrates the novel approach of controlling magnetic particles for treating malignant glioma that should be applicable to treat a wide range of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,429
Single-Domain Circular Nanomagnets
Cowburn, R. P., Koltsov, D. K., Adeyeye, A. O., Welland, M. E., & Tricker, D. M. (1999) · Physical Review Letters · doi:10.1103/physrevlett.83.1042 · Cited by 1,215
Self-citationProgrammed cell death: Apoptosis and oncogenesis
Williams, G. T. (1991) · Cell · doi:10.1016/0092-8674(91)90002-g · Cited by 826
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775
Thomas, C. R., Ferris, D. P., Lee, J.-H., Choi, E., Cho, M. H., Kim, E. S., Stoddart, J. F., Shin, J.-S., Cheon, J., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1022267 · Cited by 615
Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction
Kim, D.-H., Rozhkova, E. A., Ulasov, I. V., Bader, S. D., Rajh, T., Lesniak, M. S., & Novosad, V. (2010) · Nature Materials · doi:10.1038/nmat2591 · Cited by 611
Self-citationRemote control of cellular behaviour with magnetic nanoparticles
Dobson, J. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.39 · Cited by 528
Amstad, E., Kohlbrecher, J., Müller, E., Schweizer, T., Textor, M., & Reimhult, E. (2011) · Nano Letters · doi:10.1021/nl2001499 · Cited by 397
Zhang, F., Braun, G. B., Pallaoro, A., Zhang, Y., Shi, Y., Cui, D., Moskovits, M., Zhao, D., & Stucky, G. D. (2012) · Nano Letters · doi:10.1021/nl202949y · Cited by 377
Magnetic nanoparticles: a novel platform for cancer theranostics
Singh, A., & Sahoo, S. K. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.10.005 · Cited by 289
Domenech, M., Marrero-Berrios, I., Torres-Lugo, M., & Rinaldi, C. (2013) · ACS Nano · doi:10.1021/nn4007048 · Cited by 274
A magnetic switch for the control of cell death signalling in in vitro and in vivo systems
Cho, M. H., Lee, E. J., Son, M., Lee, J.-H., Yoo, D., Kim, J.-W., Park, S. W., Shin, J.-S., & Cheon, J. (2012) · Nature Materials · doi:10.1038/nmat3430 · Cited by 260
Dynamic Magnetic Fields Remote-Control Apoptosis via Nanoparticle Rotation
Zhang, E., Kircher, M. F., Koch, M., Eliasson, L., Goldberg, S. N., & Renström, E. (2014) · ACS Nano · doi:10.1021/nn406302j · Cited by 232
Magnetically Triggered Dual Functional Nanoparticles for Resistance‐Free Apoptotic Hyperthermia
Yoo, D., Jeong, H., Noh, S., Lee, J., & Cheon, J. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201306557 · Cited by 230
Sensenig, R., Sapir, Y., MacDonald, C., Cohen, S., & Polyak, B. (2012) · Nanomedicine · doi:10.2217/nnm.12.109 · Cited by 229
Cho, E. S., Kim, J., Tejerina, B., Hermans, T. M., Jiang, H., Nakanishi, H., Yu, M., Patashinski, A. Z., Glotzer, S. C., Stellacci, F., et al. (2012) · Nature Materials · doi:10.1038/nmat3406 · Cited by 214
Selective activation of mechanosensitive ion channels using magnetic particles
Hughes, S., McBain, S., Dobson, J., & El Haj, A. J. (2008) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.1274 · Cited by 197
Ivkov, R., DeNardo, S. J., Daum, W., Foreman, A. R., Goldstein, R. C., Nemkov, V. S., & DeNardo, G. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0016 · Cited by 186
A New X-Ray Activated Nanoparticle Photosensitizer for Cancer Treatment
Ma, L., Zou, X., & Chen, W. (2014) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1954 · Cited by 150
Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Wankhede, M., Bouras, A., Kaluzova, M., & Hadjipanayis, C. G. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.1 · Cited by 138
Ahmed, A. U., Tyler, M. A., Thaçi, B., Alexiades, N. G., Han, Y., Ulasov, I. V., & Lesniak, M. S. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200161f · Cited by 137
Self-citationMathematical Modeling of Tumor Growth and Metastatic Spreading: Validation in Tumor-Bearing Mice
Hartung, N., Mollard, S., Barbolosi, D., Benabdallah, A., Chapuisat, G., Henry, G., Giacometti, S., Iliadis, A., Ciccolini, J., Faivre, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0721 · Cited by 126
Sanchez, C., Diab, D. E. H., Connord, V., Clerc, P., Meunier, É., Pipy, B., Payré, B., Tan, R. P., Gougeon, M., Carrey, J., et al. (2014) · ACS Nano · doi:10.1021/nn404954s · Cited by 125
Modern Micro and Nanoparticle-Based Imaging Techniques
Ryvolová, M., Chomoucká, J., Drbohlavová, J., Kopel, P., Babula, P., Hynek, D., Adam, V., Eckschlager, T., Hubálek, J., Stiborová, M., et al. (2012) · Sensors · doi:10.3390/s121114792 · Cited by 98
Jia, X., & Jia, L. (2012) · Current Drug Metabolism · doi:10.2174/138920012802850074 · Cited by 86
Li, J., Qu, Y., Ren, J., Yuan, W., & Shi, D. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/50/505706 · Cited by 63
Theranostic Magnetic Nanostructures (MNS) for Cancer
Nandwana, V., De, M., Chu, S., Jaiswal, M. K., Rotz, M. W., Meade, T. J., & Dravid, V. P. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_3 · Cited by 48
The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma
Wegscheid, M. L., Morshed, R. A., Cheng, Y., & Lesniak, M. S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912629 · Cited by 31
Self-citation
Cited by
Vinod, C., & Jena, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.612692 · Cited by 45
Metadata
- Authors
- Cheng, Y., Muroski, M. E., Petit, D. C. M. C., Mansell, R., Vemulkar, T., Morshed, R. A., Han, Y., Balyasnikova, I. V., Horbinski, C. M., Huang, X., Zhang, L., Cowburn, R. P., & Lesniak, M. S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 223
- Pages
- 75-84
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2207604389
- Cited by
- 158
- References
- 31
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.